Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 79 Carcinoma, Non-Small-Cell Lung 71 Prostatic Neoplasms 68 Neoplasms 52 Multiple Myeloma 46 Lung Neoplasms 42 Colorectal Neoplasms 37 Melanoma 32 Lymphoma, Non-Hodgkin 30 Pancreatic Neoplasms 29 Neoplasm Metastasis 29 Lymphoma 28 Leukemia, Myeloid, Acute 27 Squamous Cell Carcinoma of Head and Neck 26 Ovarian Neoplasms 26 Carcinoma, Renal Cell 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Endometrial Neoplasms 22 Stomach Neoplasms 20 Sarcoma 20 Carcinoma, Hepatocellular 20 Urinary Bladder Neoplasms 19 Glioma 19 Uterine Cervical Neoplasms 18 Recurrence 18 Rectal Neoplasms 18 Lymphoma, Mantle-Cell 17 Hematologic Neoplasms 17 Head and Neck Neoplasms 17

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced Solid Neoplasms × 30 days × Clear all

NCT03742895 2026-05-15

MK-7339-002

Merck Sharp & Dohme LLC

Phase 2 Active not recruiting

Advanced Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡